ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS;UNIVERSITÉ PARIS DIDEROT (PARIS VII);UNIVERSITÉ DE NICE—SOPHIA ANTIPOLIS;INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
发明人:
Johanna Chiche,Catherine Thieblemont,Jean-Ehrland Ricci
申请号：
US15121864
公开号：
US09879325B2
申请日:
2015.02.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a method for predicting the responsiveness of a patient to a treatment with an anti-CD20 antibody, said method comprising measuring the level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression in B cells obtained from said patient.
